SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
|
Stock Warrants | ||
Number of Shares, Warrants Outstanding Beginning | 919,664 | |
Weighted-Average Exercise Price, Outstanding Beginning | $ 33.76 | |
Weighted Average Remaining Contractual Life (Years), Outstanding, Beginning | 2 years 10 months 6 days | 3 years 1 month 6 days |
Aggregate Intrinsic Value Outstanding Beginning | ||
Number of Shares, Warrants Outstanding Beginning | ||
Weighted-Average Exercise Price, Outstanding Beginning | ||
Number of Shares, Warrants Outstanding Beginning | (3,473) | |
Weighted-Average Exercise Price, Outstanding Beginning | $ 104.40 | |
Number of Shares, Warrants Outstanding Beginning | ||
Weighted-Average Exercise Price, Outstanding Beginning | ||
Number of Shares, Warrants Outstanding Beginning | 916,191 | 919,664 |
Weighted-Average Exercise Price, Outstanding Beginning | $ 33.50 | $ 33.76 |
Aggregate Intrinsic Value Outstanding Beginning |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted Average Remaining Contractual Life (Years), Outstanding, Beginning. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when warrants forfeited. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments other than options aggregate intrinsic value nonvested. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|